Zhang, Ruyue http://orcid.org/0000-0001-5747-9428
Song, Jie
Isgren, Anniella
Jakobsson, Joel
Blennow, Kaj
Sellgren, Carl M.
Zetterberg, Henrik
Bergen, Sarah E. http://orcid.org/0000-0002-5888-0034
Landén, Mikael http://orcid.org/0000-0002-4496-6451
Article History
Received: 11 August 2019
Revised: 13 January 2020
Accepted: 20 January 2020
First Online: 5 February 2020
Conflict of interest
: H.Z. has served at scientific advisory boards for Roche Diagnostics, Wave, Samumed and CogRx, has given lectures in symposia sponsored by Biogen and Alzecure, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg (all unrelated to the submitted work). J.J. has been an employee of AstraZeneca, Apr 2017-Jan 2019 (not related to the submitted work). K.B. has served as a consultant or at advisory boards for Alector, Alzheon, CogRx, Biogen, Lilly, Novartis and Roche Diagnostics, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg, all unrelated to the work presented in this paper. C.S.M. is a co-founder of Outermost Therapeutics (unrelated to the submitted work). The other authors declare no conflict of interest.